AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15071247 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-site right atrial pacing
Number of subjects: 40
Study 15071247 — intervention group
Group type: COMPARATOR
Intervention: Single-site high right atrial pacing
Number of subjects: 40
Study 12954679 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured interdisciplinary assessment of older people presenting to the accident and emergency department with a fall
Number of subjects: 0
Study 12954679 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 9862851 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without adverse factors (Stage 0)
Number of subjects: 102
Study 9862851 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with at least one adverse parameter (Stage I)
Number of subjects: 102
Study 9862851 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort of patients
Number of subjects: 102
Study 9862851 — intervention group
Group type: COMPARATOR
Intervention: Independent predictors for mortality
Number of subjects: 102
Study 8921919 — intervention group
Group type: EXPERIMENTAL
Intervention: 1987 American College of Rheumatology (ACR) criteria for classification of rheumatoid arthritis
Number of subjects: 298
Study 8921919 — intervention group
Group type: COMPARATOR
Intervention: Exclusion of disorders with obvious distinguishing extraarticular features or SF findings of monosodium urate crystals
Number of subjects: 298
Study 1928635 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed‐emphasis instructions
Number of subjects: 0
Study 1928635 — intervention group
Group type: EXPERIMENTAL
Intervention: Accuracy‐emphasis instructions
Number of subjects: 0
Study 1928635 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical instructions emphasizing speed and accuracy equally
Number of subjects: 0
Study 6404880 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornidazole 500 mg orally every 12 h for seven days
Number of subjects: 60
Study 6404880 — intervention group
Group type: COMPARATOR
Intervention: Phenoxymethylpenicillin 800 mg orally every 12 h for seven days
Number of subjects: 60
Study 30113250 — intervention group
Group type: EXPERIMENTAL
Intervention: Sense© intervention
Number of subjects: 10
Study 28971601 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-4 cups of yogurt per week
Number of subjects: 965
Study 28971601 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥5 cups of yogurt per week
Number of subjects: 965
Study 28971601 — intervention group
Group type: COMPARATOR
Intervention: <2 cups of yogurt per week (nonoverweight women)
Number of subjects: 965
Study 28971601 — intervention group
Group type: COMPARATOR
Intervention: <2 cups of yogurt per week (overweight women)
Number of subjects: 965
Study 27742968 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intermediate cervical plexus block with 5 ml of 0.75% ropivacaine
Number of subjects: 40
Study 27742968 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided intermediate cervical plexus block with 5 ml of 0.9% saline (control group)
Number of subjects: 40
Study 24656314 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystoscopy-assisted surgery (Group A)
Number of subjects: 29
Study 24656314 — intervention group
Group type: COMPARATOR
Intervention: Conventional open surgery (Group B)
Number of subjects: 29
Study 22162245 — intervention group
Group type: EXPERIMENTAL
Intervention: Virgin olive oil (VOO)
Number of subjects: 20
Study 22162245 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural antioxidants from olive mill wastewater alperujo (phenols; SOP)
Number of subjects: 20
Study 22162245 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil (SFO)
Number of subjects: 20
Study 19855076 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental muscle vibration (SMV) at 120 Hz for 30 minutes after each physical therapy session
Number of subjects: 44
Study 19855076 — intervention group
Group type: COMPARATOR
Intervention: General physical therapy
Number of subjects: 44
Study 17394730 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk of social isolation
Number of subjects: 2641
Study 17394730 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic details, social network, and risk for social isolation
Number of subjects: 2641
Study 16290961 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril plus canrenoate (25 mg/d)
Number of subjects: 510
Study 16290961 — intervention group
Group type: COMPARATOR
Intervention: Captopril alone (placebo)
Number of subjects: 510
Study 12011283 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-NF-L antibodies in PPMS and SPMS
Number of subjects: 140
Study 12011283 — intervention group
Group type: COMPARATOR
Intervention: Anti-NF-L antibodies
Number of subjects: 140
Study 12011283 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-NF-L, antitubulin, and anti-NF-H levels
Number of subjects: 140
Study 12011283 — intervention group
Group type: EXPERIMENTAL
Intervention: CSF or serum antibodies
Number of subjects: 140
Study 12011283 — intervention group
Group type: EXPERIMENTAL
Intervention: CSF oligoclonal bands reactive with NF-L
Number of subjects: 140
Study 9818584 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing sugar-free gum for 20 minutes after each of three meals a day
Number of subjects: 1402
Study 9818584 — intervention group
Group type: COMPARATOR
Intervention: Control group (no gum)
Number of subjects: 1402
Study 9818584 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing sugar-free gum for high-risk subjects
Number of subjects: 1402
Study 7710795 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of a small amount of contrast medium rapidly via the antecubital vein and measurement of aortic transit time (ATT) by single slice dynamic CT.
Number of subjects: 0
Study 7710795 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of contrast medium at a high rate, expecting peak hepatic enhancement to occur at ATT plus 8 seconds after the end of injection.
Number of subjects: 0
Study 7710795 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiral scanning of the liver using thin collimation and caudo-cranial table movement beginning at ATT after the end of contrast medium injection.
Number of subjects: 0
Study 2559897 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral iodized oil (2 ml)
Number of subjects: 6
Study 2559897 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular iodized oil (2 ml)
Number of subjects: 6
Study 2559897 — intervention group
Group type: COMPARATOR
Intervention: Control villages (no iodine supplementation)
Number of subjects: 6
Study 407559 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone valerate (BV, 800 microgram daily)
Number of subjects: 20
Study 407559 — intervention group
Group type: COMPARATOR
Intervention: Sodium cromoglycate (SCG, 80 mg daily)
Number of subjects: 20
Study 407559 — intervention group
Group type: COMPARATOR
Intervention: Placebo aerosol (single-blind)
Number of subjects: 20
Study 29679637 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent stimulant users (n=27)
Number of subjects: 55
Study 29679637 — intervention group
Group type: COMPARATOR
Intervention: Non-reactive stimulant users (n=28)
Number of subjects: 55
Study 28271623 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic capsule (BIO-25), twice daily for 8 weeks
Number of subjects: 107
Study 28271623 — intervention group
Group type: COMPARATOR
Intervention: Placebo, twice daily for 8 weeks
Number of subjects: 107
Study 28271623 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic capsule (BIO-25)
Number of subjects: 107
Study 28271623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 25681139 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug treatment with thiazides, alpha-methyldopa, and propranolol; n = 406
Number of subjects: 785
Study 25681139 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls; n = 379
Number of subjects: 785
Study 23950642 — intervention group
Group type: EXPERIMENTAL
Intervention: Memo® (750 mg lyophilized royal jelly, 120 mg G. biloba, 150 mg P. ginseng)
Number of subjects: 66
Study 23950642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 20508537 — intervention group
Group type: EXPERIMENTAL
Intervention: NEW COOL - combination of consumption of 14 g of ice slurry per kilogram body mass made from a commercial sports drink while applying iced towels
Number of subjects: 11
Study 20508537 — intervention group
Group type: EXPERIMENTAL
Intervention: STD COOL - whole‐body immersion in cold (10°C) water for 10 min followed by wearing a cooling jacket
Number of subjects: 11
Study 20508537 — intervention group
Group type: COMPARATOR
Intervention: CON - no treatment apart from the ad libitum consumption of cold water (4°C)
Number of subjects: 11
Study 18446389 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling, root planning, and chlorhexidine rinses for 3 months with systemic administration of doxycycline (100 mg once a day for 15 days)
Number of subjects: 60
Study 18446389 — intervention group
Group type: COMPARATOR
Intervention: Scaling, root planning, and chlorhexidine rinses for 3 months without systemic administration of doxycycline
Number of subjects: 60
Study 16531178 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg followed by vaginal misoprostol 800 mcg after 6-8 hours
Number of subjects: 1080
Study 16531178 — intervention group
Group type: COMPARATOR
Intervention: Mifepristone 200 mg followed by vaginal misoprostol 800 mcg after 24 hours
Number of subjects: 1080
Study 12951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic reviews discussing resistance
Number of subjects: 111
Study 12951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic reviews collecting data on patient response to resistant isolates
Number of subjects: 111
Study 12951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic reviews collecting data on induction of resistance
Number of subjects: 111
Study 12951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic reviews highly relevant to resistance
Number of subjects: 111
Study 12951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Articles discussing or collecting data on resistance
Number of subjects: 111
Study 12951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Articles providing actual data on resistance
Number of subjects: 111
Study 12951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Articles providing data on efficacy in susceptible and resistant pathogens
Number of subjects: 111
Study 12951336 — intervention group
Group type: EXPERIMENTAL
Intervention: Articles providing data on infection or colonization with resistant strains
Number of subjects: 111
Study 11561298 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophoresis of sodium oxybutirate
Number of subjects: 177
Study 11561298 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophoresis of alpha‐tocopherol
Number of subjects: 177
Study 11561298 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophoresis of dimexide
Number of subjects: 177
Study 11561298 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study 9423974 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmachinery based system
Number of subjects: 343
Study 9423974 — intervention group
Group type: COMPARATOR
Intervention: Machinery based system
Number of subjects: 343
Study 8353575 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparinized flush solutions
Number of subjects: 5139
Study 8353575 — intervention group
Group type: COMPARATOR
Intervention: Nonheparinized flush solutions
Number of subjects: 5139
Study 2962603 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrizoate 350 mg I/ml
Number of subjects: 60
Study 2962603 — intervention group
Group type: COMPARATOR
Intervention: Iohexol 350 mg I/ml
Number of subjects: 60
Study 1699631 — intervention group
Group type: EXPERIMENTAL
Intervention: NdYAG laser recanalization
Number of subjects: 40
Study 1699631 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic intubation
Number of subjects: 40
Study 31023190 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based educational intervention plus peer support-moderated listserv
Number of subjects: 131
Study 31023190 — intervention group
Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 131
Study 27966042 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine artery embolization (UAE) using tris-acryl gelatin microspheres ≥500 μm
Number of subjects: 15
Study 27966042 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine artery embolization (UAE)
Number of subjects: 15
Study 26350448 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified school snack
Number of subjects: 1047
Study 26350448 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation and deworming
Number of subjects: 1047
Study 26350448 — intervention group
Group type: EXPERIMENTAL
Intervention: Fever and poultry ownership
Number of subjects: 1047
Study 23303058 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (400 mg)
Number of subjects: 2
Study 23303058 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg)
Number of subjects: 2
Study 23303058 — intervention group
Group type: COMPARATOR
Intervention: Placebo (200 mg at 2300 hours and 200 mg at 0400 hours)
Number of subjects: 2
Study 23303058 — intervention group
Group type: COMPARATOR
Intervention: Placebo (200 mg at 2300 hours)
Number of subjects: 2
Study 21112791 — intervention group
Group type: EXPERIMENTAL
Intervention: Martínez-Gimeno Score System (MGSS)
Number of subjects: 40
Study 21112791 — intervention group
Group type: EXPERIMENTAL
Intervention: CT scan
Number of subjects: 40
Study 21112791 — intervention group
Group type: EXPERIMENTAL
Intervention: Palpation
Number of subjects: 40
Study 21112791 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of MGSS and clinical palpation
Number of subjects: 40
Study 19882368 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone (MTX)
Number of subjects: 0
Study 17568248 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling training
Number of subjects: 0
Study 17568248 — intervention group
Group type: COMPARATOR
Intervention: Control educational intervention
Number of subjects: 0
Study 12847946 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 84
Study 12847946 — intervention group
Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 84
Study 10553492 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapse prevention treatment
Number of subjects: 0
Study 10553492 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 8728532 — intervention group
Group type: EXPERIMENTAL
Intervention: Wobble board training for 12 weeks
Number of subjects: 61
Study 8728532 — intervention group
Group type: COMPARATOR
Intervention: No training
Number of subjects: 61
Study 8728532 — intervention group
Group type: EXPERIMENTAL
Intervention: Wobble board training
Number of subjects: 61
Study 1867367 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.0027 mg/kg fentanyl alone
Number of subjects: 10
Study 1867367 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.0027 mg/kg fentanyl and 1 mg flumazenil i.v. over 4 min
Number of subjects: 10
Study 6138063 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg midazolam
Number of subjects: 6
Study 6138063 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg midazolam
Number of subjects: 6
Study 6138063 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg midazolam
Number of subjects: 6
Study 6138063 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (10, 20, 30 mg)
Number of subjects: 6
Study 6138063 — intervention group
Group type: COMPARATOR
Intervention: Brotizolam (0.25 mg)
Number of subjects: 6
Study 30380356 — intervention group
Group type: EXPERIMENTAL
Intervention: β-glucan beverage (250 mL/day containing 250 mg of dispersible baker's yeast β‐glucan)
Number of subjects: 357
Study 30380356 — intervention group
Group type: EXPERIMENTAL
Intervention: β-glucan beverage
Number of subjects: 357
Study 30328699 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum-AC (verum acupoints)
Number of subjects: 105
Study 30328699 — intervention group
Group type: COMPARATOR
Intervention: Control-AC (sham acupoints)
Number of subjects: 105
Study 30328699 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 105
Study 29528296 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusion
Number of subjects: 44
Study 29528296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 25348221 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 40
Study 25348221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 23998560 — intervention group
Group type: EXPERIMENTAL
Intervention: BIAsp 30
Number of subjects: 521
Study 23998560 — intervention group
Group type: COMPARATOR
Intervention: IGlar
Number of subjects: 521
Study 21463153 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy plus CABG
Number of subjects: 1212
Study 21463153 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 1212
Study 21463153 — intervention group
Group type: EXPERIMENTAL
Intervention: Viable myocardium
Number of subjects: 1212
Study 21463153 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-viable myocardium
Number of subjects: 1212
Study 21463153 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment assignment
Number of subjects: 1212
Study 19674449 — intervention group
Group type: EXPERIMENTAL
Intervention: semi-standardised acupuncture
Number of subjects: 336
Study 19674449 — intervention group
Group type: EXPERIMENTAL
Intervention: gabapentine (900-3600 mg/d)
Number of subjects: 336
Study 19674449 — intervention group
Group type: COMPARATOR
Intervention: sham laser acupuncture
Number of subjects: 336
Study 19674449 — intervention group
Group type: EXPERIMENTAL
Intervention: gabapentine
Number of subjects: 336
Study 17111004 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex-LG (exercise before low-GI meal)
Number of subjects: 8
Study 17111004 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex-HG (exercise before high-GI meal)
Number of subjects: 8
Study 17111004 — intervention group
Group type: COMPARATOR
Intervention: LG-Ex (low-GI meal before exercise)
Number of subjects: 8
Study 17111004 — intervention group
Group type: COMPARATOR
Intervention: HG-Ex (high-GI meal before exercise)
Number of subjects: 8
Study 15351418 — intervention group
Group type: EXPERIMENTAL
Intervention: Unicompartmental knee replacement (UKR)
Number of subjects: 30
Study 11050375 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle acupuncture (verum)
Number of subjects: 39
Study 11050375 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 39
Study 9190629 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid therapy (low dose)
Number of subjects: 48
Study 9190629 — intervention group
Group type: COMPARATOR
Intervention: Control group (36 healthy persons)
Number of subjects: 48
Study 1403587 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine irrigant during ultrasonic scaling
Number of subjects: 0
Study 1403587 — intervention group
Group type: COMPARATOR
Intervention: Water irrigant during ultrasonic scaling
Number of subjects: 0
Study 1403587 — intervention group
Group type: EXPERIMENTAL
Intervention: New model ultrasonic scaler
Number of subjects: 0
Study 1403587 — intervention group
Group type: COMPARATOR
Intervention: Traditional model ultrasonic scaler
Number of subjects: 0
Study 2936564 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin acetate 250 micrograms daily
Number of subjects: 24
Study 2936564 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin acetate 125 micrograms daily
Number of subjects: 24
Study 2936564 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of nafarelin acetate
Number of subjects: 24
Study 30126714 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual instructions plus a three-minute card with language-specific audio instructions
Number of subjects: 83
Study 30126714 — intervention group
Group type: COMPARATOR
Intervention: Usual discharge instructions
Number of subjects: 83
Study 29747366 — intervention group
Group type: EXPERIMENTAL
Intervention: Proming(®)Toric IOL (Model: AT1BH‐AT6BH)
Number of subjects: 121
Study 29747366 — intervention group
Group type: COMPARATOR
Intervention: AcrySof(®)IQ Toric IOL (Model: SN6AT2‐SN6AT7)
Number of subjects: 121
Study 28721298 — intervention group
Group type: EXPERIMENTAL
Intervention: Single IM hydrocortisone sodium succinate injection plus ordinary post‐operative treatment
Number of subjects: 117
Study 28721298 — intervention group
Group type: COMPARATOR
Intervention: Post‐operative treatment alone
Number of subjects: 117
Study 26180028 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG-IUS
Number of subjects: 100
Study 26180028 — intervention group
Group type: COMPARATOR
Intervention: Cu-IUD
Number of subjects: 100
Study 23126367 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (200 ml thrice daily for 4 days)
Number of subjects: 10
Study 23126367 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 10
Study 20947384 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus (SIR) based immunosuppressive regimen
Number of subjects: 181
Study 20947384 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus (TAC)/azathioprine (AZA)/prednisone immunosuppressive regimen
Number of subjects: 181
Study 19027432 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based behavioral treatment emphasizing problem solving and activity scheduling
Number of subjects: 64
Study 17135988 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 439
Study 17135988 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 439
Study 17135988 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Fluoxetine + CBT)
Number of subjects: 439
Study 17135988 — intervention group
Group type: COMPARATOR
Intervention: Clinical management with pill placebo
Number of subjects: 439
Study 14514569 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin therapy, 40 mg/day over 6.0 years
Number of subjects: 2017
Study 14514569 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2017
Study 10919939 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glycemic-index breakfast cereal
Number of subjects: 91
Study 10919939 — intervention group
Group type: EXPERIMENTAL
Intervention: High-glycemic-index breakfast cereal
Number of subjects: 91